Skip to Content
Merck
All Photos(1)

Key Documents

444375

Sigma-Aldrich

N-Benzoyl-(2R,3S)-3-phenylisoserine

98%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
C6H5CONHCH(C6H5)CH(OH)CO2H
CAS Number:
Molecular Weight:
285.29
MDL number:
UNSPSC Code:
12352209
eCl@ss:
32160406
PubChem Substance ID:
NACRES:
NA.22

Assay

98%

optical activity

[α]20/D −40°, c = 1.0 in ethanol

reaction suitability

reaction type: solution phase peptide synthesis

mp

169-172 °C (lit.)

application(s)

peptide synthesis

SMILES string

O[C@H]([C@@H](NC(=O)c1ccccc1)c2ccccc2)C(O)=O

InChI

1S/C16H15NO4/c18-14(16(20)21)13(11-7-3-1-4-8-11)17-15(19)12-9-5-2-6-10-12/h1-10,13-14,18H,(H,17,19)(H,20,21)/t13-,14+/m0/s1

InChI key

HYJVYOWKYPNSTK-UONOGXRCSA-N

Application

The presence of this chiral side chain has proven to be essential for the biological activity of taxol, one of the most promising anticancer agents being investigated. The challenging synthesis of taxol has stimulated interest in the attachment of the C-13 side chain to naturally derived taxanes like baccatin III.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ojima, I. et al.
Tetrahedron, 48, 6985-6985 (1992)
Mangatal, L. et al.
Tetrahedron, 45, 4177-4177 (1989)
Holton, R.A. et al.
Journal of the American Chemical Society, 116, 1597-1597 (1994)
Ojima, I. et al.
Tetrahedron Letters, 34, 4149-4149 (1993)
E K Rowinsky et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9(9), 1692-1703 (1991-09-01)
Untreated and minimally pretreated solid tumor patients received alternating sequences of taxol and cisplatin. Sequential dose escalation of each agent using taxol doses of 110 or 135 mg/m2 and cisplatin doses of 50 or 75 mg/m2 resulted in four dosage

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service